TMO
Original en la caja:
hetzbox:archivo/lengua/fuentes/macbook/TMO.csv· fecha del fichero: 2017-08-24 19:15 · formato original: .csv · convertido el 21/10/2026 13:03 (E-1154 · Karb and Sil).
| Class ID | Preferred Label | Synonyms | Definitions | Obsolete | CUI | Semantic Types | Parents | attribute of | HapMap population name abbreviation | has attribute | has role | has unit | has value | http://data.bioontology.org/metadata/obo/part_of | http://data.bioontology.org/metadata/prefixIRI | http://data.bioontology.org/metadata/treeView | http://purl.obolibrary.org/obo/IAO_0000004 | http://purl.obolibrary.org/obo/IAO_0000119 | http://purl.obolibrary.org/obo/IAO_0000136 | http://purl.obolibrary.org/obo/IAO_0000404 | http://purl.obolibrary.org/obo/IAO_0000405 | http://purl.obolibrary.org/obo/IAO_0000406 | http://purl.org/dc/elements/1.1/creator | http://purl.org/dc/elements/1.1/description | http://purl.org/dc/elements/1.1/publisher | http://purl.org/dc/elements/1.1/rights | http://purl.org/dc/elements/1.1/subject | http://purl.org/dc/elements/1.1/title | http://purl.org/obo/owl/OBO_REL#bearer_of | http://spinrdf.org/spin#imports | http://www.geneontology.org/formats/oboInOwl#hasDbXref | http://www.obofoundry.org/ro/ro.owl#has_integral_part | http://www.obofoundry.org/ro/ro.owl#has_part | http://www.obofoundry.org/ro/ro.owl#has_proper_part | http://www.obofoundry.org/ro/ro.owl#integral_part_of | http://www.obofoundry.org/ro/ro.owl#located_in | http://www.obofoundry.org/ro/ro.owl#location_of | http://www.obofoundry.org/ro/ro.owl#part_of | http://www.obofoundry.org/ro/ro.owl#proper_part_of | http://www.w3.org/2000/01/rdf-schema#label | in relation to | is described by | is variant of | provides supporting evidence for | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0070 | diagnostic exclusion criterion | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0068 | transmed:TMO_0070 | A diagnostic exclusion criterion is a diagnostic criterion for consideration during a diagnosis which, if satisfied, excludes a diagnostic result. | IAO:0000124 | diagnostic exclusion criterion | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0105 | multitude numerical quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0121 | transmed:TMO_0105 | A multitude numerical quantity is a numerical quantity that indicates the number of individuals. | multitude numerical quantity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0083 | ethnicity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | transmed:TMO_0083 | Ethinicity is the quality of an organism that describes membership in a social group based on a common heritage. | ethnicity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0118 | indicator | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0118 | An indicator is an entity for which its observation/detection is used in some objective. | indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0153 | nucleotide residue | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0153 | nucleotide residue | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0123 | amino acid sequence position | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0119 | transmed:TMO_0123 | An amino acid sequence position indicates the position of an amino acid residue in relation to the start of the peptide chain. | amino acid sequence position | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0018 | environmental description | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | transmed:TMO_0018 | An environmental description is a description concerning some aspect of a physical environment. | IAO:0000123 | environmental description | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0171 | gene name | false | http://purl.obolibrary.org/obo/IAO_0000009 | transmed:TMO_0171 | gene name | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000400 | IAO_0000400 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0116 | obo2:IAO_0000400 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0141 | reference genomic sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0138 | transmed:TMO_0141 | A reference genomic sequence is a genomic sequence that serves as a standard or reference, and may be composed by the consensus of the genomes of a number of individuals or parts thereof. | reference genomic sequence | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0036 | cell line | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0045 | transmed:TMO_0036 | A cell line is a material entity that consists of a population of cells cultured in vitro that are descended through one or more generations (and possible sub-cultures) from a single primary culture which was originally derived from part of an organism. | EFO:0000322\ | UMLS:C0007600\ | NCIt:Cell_Line\ | BIRNLex:11036\ | MSH:D002460 | cell line | ||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0006 | subject role | false | http://www.ifomis.org/bfo/1.1/snap#Role | transmed:TMO_0006 | A role played by a material entity it being the subject of a study. | UMLS:C1521840\ | NCIt:Target | subject role | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000030 | IAO_0000030 | false | obo2:IAO_0000030 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0041 | disease progression | false | http://www.ifomis.org/bfo/1.1/span#ProcessualEntity | transmed:TMO_0041 | NCIt:Disease_Progression\ | MSH:D018450\ | OBI:0000354\ | UMLS:C0242656\ | IAO:0000124\ | NDFRT:C7812 | disease progression | ||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0054 | lifestyle | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0097 | transmed:TMO_0054 | Lifestyle is a description about an individual`s manner of living. | SNOMEDCT:367150003\ | NCIt:Lifestyle\ | MSH:D008019\ | SNOMEDCT:366925008\ | UMLS:C0023676\ | SNOMEDCT:134436002\ | IAO:0000121 | lifestyle | ||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000306 | IAO_0000306 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | obo2:IAO_0000306 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0164 | organization | false | http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant | transmed:TMO_0164 | organization | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0040 | drug-drug interaction | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304 | transmed:TMO_0040 | A drug-drug interaction is a drug interaction in which two drugs interact in such a way to produce an abnormal phenotypic event. | SNOMEDCT:404204005\ | IAO:0000124 | drug-drug interaction | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0110 | statistical quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0120 | transmed:TMO_0110 | statistical quantity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0129 | protein sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0128 | transmed:TMO_0129 | An amino acid sequence is a sequence of amino acids in which a word (1 more more sequence of characters) represents an amino acid and their adjacency indicates their connectivity. | protein sequence\ | amino acid sequence | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0094 | quantity | false | http://purl.obolibrary.org/obo/IAO_0000030 | transmed:TMO_0094 | A quantity is a quantitative measure of some feature. | quantity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0182 | centimeter | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0104 | transmed:TMO_0182 | centimeter | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0029 | study | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0075 | transmed:TMO_0029 | A study is a planned process that consists of planning, study execution, documentation and the production of conclusion(s). | SNOMEDCT:224699009\ | OBI:0000471\ | OCRe_research:Study\ | NCIt:Study\ | UMLS:C0947630\ | IAO:0000121\ | LNC:LP74341-6 | study | ||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0217 | genetic status | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0217 | genetic status | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0195 | smoker status | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0194 | transmed:TMO_0195 | Smoker status is a medical descriptor of the tobacco smoking behaviour of a person. | smoker status | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0047 | disease | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | transmed:TMO_0047 | Richard Scheuermann, Werner Ceusters, Barry Smith in "Toward an Ontological Treatment of Disease and Diagnosis""" | A quality of an organism which predisposes it to undergo pathological processes because of one or more disorders in that organism. | NDFRT:C2140\ | ACGT:Disease\ | BIRNLex:11013\ | OBI:0000155\ | NCIt:Disease_or_Disorder\ | diseasome:diseases\ | MSH:D004194\ | GRO:Disease\ | pharmgkb:Disease\ | UMLS:C0012634\ | LNC:LP21006-9\ | linkedct:condition\ | DOID:4 | disease | |||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0078 | enzyme | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0035 | transmed:TMO_0078 | An enzyme is a protein that catalyzes (increases the rate of) a chemical reaction. | drugbank:enzymes | enzyme | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0011 | molecular structure description | Examples: connection table, fragment, pharmacophore. | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0106 | transmed:TMO_0011 | A molecular structure description is a description of a molecule in terms of its composition and connectivity. | molecular structure description | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0052 | biomarker | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0019 | transmed:TMO_0052 | A biomarker is a characteristic of a material entity that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. | MSH:D054316\ | UMLS:C1955886\ | NCIt:Biomarker\ | IAO:0000121 | biomarker | |||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0065 | inactive ingredient role | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0062 | transmed:TMO_0065 | An inactive ingredient role is a role played by a chemical substance which is part of a pharmaceutical formulation but does not have the disposition to treat a certain disease. | inactive ingredient role | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0051 | treatment safety value | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100 | transmed:TMO_0051 | NCI Thesaurus | Treatment safety is a condition that refers to an absence of harmful side effects resulting from use of the product and may be assessed by laboratory testing of biological samples, special tests and procedures, psychiatric evaluation, and/or physical examination of subjects. | IAO:0000124 | treatment safety value | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0121 | numerical quantity selected from a discrete variable | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0099 | transmed:TMO_0121 | numerical quantity selected from a discrete variable | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0134 | three letter amino acid sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0129 | transmed:TMO_0134 | three letter amino acid sequence | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0175 | invariant nucleic acid region | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0175 | invariant nucleic acid region | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0188 | mass per unit time | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0104 | transmed:TMO_0188 | mass per unit time | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0193 | International Normalized Ratio on the Therapeutic Dose of Warfarin | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0192 | transmed:TMO_0193 | International Normalized Ratio on the Therapeutic Dose of Warfarin | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0228 | molecular entity part | A part of a molecular entity or a set of molecular entities. It can be made up of several non-connected sub-parts, potentially on separate molecular entities. | false | http://www.ifomis.org/bfo/1.1/snap#MaterialEntity | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | transmed:TMO_0228 | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | molecular entity part | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0152 | chromosome | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0168 | transmed:TMO_0152 | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0220 | chromosome | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant | GenericallyDependentContinuant | false | http://www.w3.org/2002/07/owl#Thing | snap:GenericallyDependentContinuant | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0004 | absent phenotype | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0019 | transmed:TMO_0004 | An absent phenotype is a phenotype that represents the notable absence of a characteristic. | absent phenotype | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0017 | evidence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0017 | Evidence is a group of indicators that are relevant in some decision-making process. | IAO:0000123\ | UMLS:C0332120\ | NCIt:Evidence | evidence | ||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0058 | syndrome | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | transmed:TMO_0058 | A syndrome is a group of signs and symptoms that characterize a particular abnormality. | MSH:D013577\ | DOID:225\ | EFO:0000716\ | EFO:0000428\ | NCIt:Syndrome\ | UMLS:C0039082\ | ACGT:Syndrome | syndrome | ||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0022 | sign | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0019 | transmed:TMO_0022 | Richard Scheuermann, Werner Ceusters, Barry Smith in "Toward an Ontological Treatment of Disease and Diagnosis""" | A quality of a patient, a material entity that is part of a patient, or a processual entity that a patient participates in, any one of which is observed in a physical examination and is deemed by the clinician to be of clinical significance. | UMLS:C0311392\ | SNOMEDCT:72670004\ | NCIt:Sign | sign | |||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0076 | assay | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0075 | transmed:TMO_0076 | An assay is a planned process with the objective to obtain information about a material entity. | EFO:0001455\ | Galen:Assay\ | BIRNLex:11025\ | cto_asyont:Assay\ | SNOMEDCT:272392009\ | OBI:0000070\ | MSH:Q000032\ | PATO:0000003\ | NCIt:Assay\ | UMLS:C1510438 | assay | |||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | description | false | http://purl.obolibrary.org/obo/IAO_0000030 | transmed:TMO_0089 | description | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0159 | item in sequence identifier | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0158 | transmed:TMO_0159 | An item in a collection identifier is an identifier for an entity that is a member of an ordered sequence of items (based on some attribute). | item in sequence identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0132 | RNA sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0130 | transmed:TMO_0132 | RNA sequence | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0145 | mouse | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0144 | transmed:TMO_0145 | mouse | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0215 | DNA region | A DNA region is a part of a DNA molecule that is made up of a continous chain of deoxyribonucleotide residues. | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0228 | transmed:TMO_0215 | DNA region | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0150 | length value | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0146 | transmed:TMO_0150 | length value | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0163 | ncbi submitter snp identifier | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0161 | transmed:TMO_0163 | ncbi submitter snp identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0220 | DNA | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | transmed:TMO_0220 | DNA | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0063 | chemical substance | false | http://www.ifomis.org/bfo/1.1/snap#MaterialEntity | transmed:TMO_0063 | A chemical substance is a material entity consisting of many chemical entities and typically has connected boundaries. | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | chemical substance | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.ifomis.org/bfo/1.1/snap#Quality | Quality | false | http://www.w3.org/2002/07/owl#Thing | snap:Quality | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0028 | market | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0025 | transmed:TMO_0028 | market | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0103 | enumerated numerical quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0121 | transmed:TMO_0103 | An enumerated numerical quantity is a numerical quantity selected from a discrete set of quantities. | enumerated numerical quantity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0116 | spatial positional datum | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0137 | transmed:TMO_0116 | spatial positional datum | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0081 | haplotype | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0172 | transmed:TMO_0081 | A haplotype a variant DNA region which contains several smaller variant DNA regions which tend to be inherited together. | haplotype | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0156 | dsDNA | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0168 | transmed:TMO_0156 | dsDNA | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0226 | genotype with short tandem repeat variation | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0080 | transmed:TMO_0226 | genotype with short tandem repeat variation | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0102 | scale numerical value | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0101 | transmed:TMO_0102 | scale numerical value | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.ifomis.org/bfo/1.1/snap#Continuant | Continuant | false | http://www.w3.org/2002/07/owl#Thing | snap:Continuant | dcterms:AgentClass\ | dcterms:Agent\ | foaf:Agent | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000442 | IAO_0000442 | false | obo2:IAO_0000442 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0002 | pharmaceutical product | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0001 | transmed:TMO_0002 | A pharmaceutical product is a formulated pharmaceutical that has been approved to treat patients. | NCIt:Finished_Pharmaceutical_Product\ | UMLS:C1708062 | pharmaceutical product | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0174 | deletion | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0174 | deletion | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0015 | diagnostic result | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0136 | transmed:TMO_0015 | A diagnostic result is a medical measure of determining the nature of a problem or illness through medical procedure. | IAO:0000124 | diagnostic result | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0069 | diagnostic inclusion criterion | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0068 | transmed:TMO_0069 | A diagnostic inclusion criterion is a diagnostic criterion for consideration during a diagnosis which, if satisfied, supports a diagnostic result. | IAO:0000124 | diagnostic inclusion criterion | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0020 | personal medical history | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0098 | transmed:TMO_0020 | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0124 | A personal medical history is a medical record consisting of a collection of information obtained from the patient and from other sources concerning the patient's health. | UMLS:C0262926\ | pchr:Encounter\ | NCIt:Personal_Medical_History | personal medical history | |||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0033 | drug measure | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0010 | transmed:TMO_0033 | A drug measure is a biomedical measure that describes or is a measure of drugs or their activies. | drug measure | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | obsolete | false | http://www.w3.org/2002/07/owl#Thing | transmed:TMO_0109 | obsolete | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0074 | expert role | false | http://www.ifomis.org/bfo/1.1/snap#Role | transmed:TMO_0074 | An expert role is a role played by a knowledgeable person. | expert role | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0087 | male | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0086 | transmed:TMO_0087 | Male is a sex quality for which sex organs contain only male gametes | male | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0127 | ribonucleotide sequence position | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0125 | transmed:TMO_0127 | A ribonucleotide sequence position is an ordinal number which reflects the position of a ribonucleotide in relation to the first ribonucleotide of the same ribonucleic acid (RNA). | ribonucleotide sequence position | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0092 | comparative description | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | transmed:TMO_0092 | comparative description | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0161 | snp identifier | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0159 | transmed:TMO_0161 | snp identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0008 | patient role | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0060 | transmed:TMO_0008 | A patient role is a role played a human subject that receives medical attention, care or treatment or who is registered with a medical institution with the purpose of receiving medical care when necessary. | patient role | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000302 | IAO_0000302 | false | http://purl.obolibrary.org/obo/IAO_0000009 | obo2:IAO_0000302 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000313 | IAO_0000313 | false | http://purl.obolibrary.org/obo/IAO_0000310 | obo2:IAO_0000313 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0026 | regulatory authority | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0025 | transmed:TMO_0026 | A regulatory authority is an institution created by legislation which acts to control what treatments can be prescribed. | regulatory authority | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0039 | genotype with copy number variation | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0080 | transmed:TMO_0039 | A genotype of which variants with a different number of copies of a sequence identifical region exist. | SO:0001019 | genotype with copy number variation | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0013 | exclusion criterion for clinical trial | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0077 | transmed:TMO_0013 | An exclusion criterion for clinical trial is a clinical trial criterion which, if satisfied, supports the exclusion of candidate patients. | IAO:0000124 | exclusion criterion for clinical trial | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0031 | diagnosis | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0029 | transmed:TMO_0031 | NCI thesaurus | A diagnosis is a study composed of investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation. | MSH:D003933\ | LNC:LP72437-4\ | NCIt:Diagnosis\ | UMLS:C0011900\ | OBI:0000075\ | OCRe_clinical:Diagnosis\ | Galen:Diagnosis\ | SNOMEDCT:439401001\ | ACGT:Diagnosis\ | FHHO:Diagnosis | diagnosis | ||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0044 | pathway | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0090 | transmed:TMO_0044 | NCI Thesaurus | A pathway is a representation of a set or series of interactions, often forming a network, which biologists have found useful to group together for organizational, historic, biophysical, or other reasons. | NCIt:Pathway\ | IEV:0000001\ | GRO:Pathway\ | MI:0619\ | Galen:Pathway | pathway | |||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0098 | medical history | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0097 | transmed:TMO_0098 | medical history | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0114 | pharmacokinetic measure | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100 | transmed:TMO_0114 | pharmacokinetic measure | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0062 | pharmaceutical ingredient role | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0073 | transmed:TMO_0062 | A pharmaceutical ingredient role is a role played by a chemical substance that is part of a pharmaceutical formulation. | pharmaceutical ingredient role | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0172 | variant DNA region | A variant DNA region is a DNA region of which variants with altered sequence exist in different individuals of the same species or in different samples of the same individual (e.g., genetic variation within an individual, such as mutations in a cancerous tumor). The number of nucleotide residues in different variants can differ (e.g., because of insertions and deletions). | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0215 | transmed:TMO_0172 | variant DNA region | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0019 | phenotype | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | transmed:TMO_0019 | A phenotype is an observable characteristic of an organism. | phenotype | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0190 | dose | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0113 | transmed:TMO_0190 | dose | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0037 | gene | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0215 | transmed:TMO_0037 | A gene is a part of DNA that encodes information about other molecular entities. | FMA:Structural_gene\ | MSH:D005796\ | UMLS:C0017337\ | PRO:Gene\ | NCIt:Gene_Object\ | GRO:Gene\ | pharmgkb:Gene\ | Galen:Gene\ | diseasome:genes\ | NCIt:Gene\ | LNC:LP32747-5\ | SNOMEDCT:67271001\ | NDFRT:C242394\ | SO:0000704 | gene | |||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0085 | age | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | transmed:TMO_0085 | Age is the temporal quality of an organism that refers to the length of time elapsed since it came into existence. For most animals and humans, age refers to the length of time elapsed since birth. | age | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0055 | health outcome | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0135 | transmed:TMO_0055 | A health outcome is a medical measure of health or loss of health. | linkedct:primary_outcomes\ | IAO:0000121\ | linkedct:secondary_outcomes | health outcome | ||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0125 | nucleotide sequence position | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0119 | transmed:TMO_0125 | A nucleotide sequence position indicates the position of a nucleotide residue in relation to the start of the nucleic acid. | nucleotide sequence position | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0138 | genomic sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0128 | transmed:TMO_0138 | A genomic sequence is the collection of sequences that make up an individual's genetic matter. | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0130 | genomic sequence | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0001 | formulated pharmaceutical | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0063 | transmed:TMO_0001 | A formulated pharmaceutical is a chemical substance whose granular parts include an active ingredient, an excipient, and possibly a stability regulator for the active ingredient. | drugbank:drugs\ | UMLS:C1705957\ | NCIt:Pharmaceutical_Formulation\ | dailymed:drugs\ | medicare:drugs\ | sider:drugs\ | pharmgkb:Drug | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0071 | formulated pharmaceutical | |||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0197 | pharmgkb subject identifier | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0158 | transmed:TMO_0197 | pharmgkb subject identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000303 | IAO_0000303 | false | http://purl.obolibrary.org/obo/IAO_0000009 | obo2:IAO_0000303 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0073 | chemical entity role | false | http://www.ifomis.org/bfo/1.1/snap#Role | transmed:TMO_0073 | A chemical entity role is a role played by a chemical entity. | chemical entity role | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0143 | patient record | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0135 | transmed:TMO_0143 | patient record | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0024 | medical measure | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0010 | transmed:TMO_0024 | A medical measure is a measure that describes or is a measure of medically relevant entities. | medical measure | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0096 | non toxic | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0056 | transmed:TMO_0096 | non toxic | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0042 | mechanism of action | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0090 | transmed:TMO_0042 | The mechanism of action is a description of processes and behaviour of a biologically active molecule in its administration into a living system. | NCIt:Mechanism_of_Action | mechanism of action | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0012 | patent | false | http://purl.obolibrary.org/obo/IAO_0000310 | transmed:TMO_0012 | American Heritage(R) Stedman's Medical Dictionary | A patent is an information entity granted by a patent office which confers upon the patenter the sole right to make, use and sell an invention for a set period of time. | MSH:D020490\ | Galen:patent\ | IAO:0000313\ | BIRNLex:2364\ | BRO:Patent | patent | |||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0060 | clinical subject role | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0006 | transmed:TMO_0060 | A clinical subject role is the role played by an organism who is the subject of a clinical procedure or assessment. | OCRe_clinical:Subject | clinical subject role | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0136 | medical finding | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0135 | transmed:TMO_0136 | medical finding | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0149 | mass value | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0146 | transmed:TMO_0149 | mass value | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0219 | genetic test | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0076 | transmed:TMO_0219 | genetic test | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0154 | amino acid residue | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0154 | amino acid residue | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0113 | temporal functional quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100 | transmed:TMO_0113 | temporal functional quantity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0167 | nucleic acid | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0167 | nucleic acid | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.ifomis.org/bfo/1.1/snap#Disposition | Disposition | false | http://www.w3.org/2002/07/owl#Thing | snap:Disposition | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100 | functional quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0120 | transmed:TMO_0100 | A functional quantity is a quantity obtained as a result of a function involving one or more parameters. | functional quantity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000109 | IAO_0000109 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0099 | obo2:IAO_0000109 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.ifomis.org/bfo/1.1/span#ProcessualEntity | ProcessualEntity | false | http://www.w3.org/2002/07/owl#Thing | span:ProcessualEntity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0035 | protein | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | transmed:TMO_0035 | A biological macromolecule that is composed of amino acids linked in a linear sequence (a polypeptide chain). | SNOMEDCT:88878007\ | NCIt:Protein\ | ACGT:Protein\ | CHEBI:36080\ | GRO:Protein\ | Galen:Protein\ | UMLS:C0033684\ | BIRNLex:23\ | ODGI:Protein\ | SO:0000358\ | FMA:Protein\ | PRO:000000001\ | GO:0003675 | protein | ||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0048 | allele | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0215\ | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0172 | transmed:TMO_0048 | An allele is a specific variant of a gene. | SO:0001023 | allele | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0053 | comparative effectiveness | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0092 | transmed:TMO_0053 | Comparative effectiveness is a drug measure that provides information about which treatment works best, for whom, and under what circumstances. | IAO:0000121 | comparative effectiveness | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0066 | molecular target | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | transmed:TMO_0066 | A molecular target is a molecular entity that is the target of a transformation process. | drugbank:targets | molecular target | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000009 | IAO_0000009 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0137 | obo2:IAO_0000009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | organismal quality | false | http://www.ifomis.org/bfo/1.1/snap#Quality | transmed:TMO_0084 | organismal quality | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0106 | physical description | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | transmed:TMO_0106 | physical description | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0071 | pharmaceutical ingredient | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0063 | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0001 | transmed:TMO_0071 | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0001 | A pharmaceutical ingredient is a chemical substance that is part of a formulated pharmaceutical that bears a pharmaceutical ingredient role. | dailymed:ingredients | pharmaceutical ingredient | ||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0111 | p-value | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0110 | transmed:TMO_0111 | p-value | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0124 | human | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0144 | transmed:TMO_0124 | human | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0178 | age | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0147 | transmed:TMO_0178 | age | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000308 | IAO_0000308 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | obo2:IAO_0000308 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0059 | hypothesis | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | transmed:TMO_0059 | A hypothesis is an information content entity that describes a possible correlation between two or more variables. | NCIt:Hypothesis\ | UMLS:C1512571\ | OBI:0000074 | hypothesis | ||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0304 | drug interaction | false | http://www.ifomis.org/bfo/1.1/span#ProcessualEntity | transmed:TMO_0304 | A drug interaction is a process in which a drug interacts with a living system in such a way that it affects its behaviour. | drugbank:drug_interactions\ | pharmgkb:DrugGeneVariantInteraction\ | pharmgkb:Association | drug interaction | ||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0005 | genetic description | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | transmed:TMO_0005 | A genetic description is a description of the genetic composition of some entity. | genetic description | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0046 | arm of clinical study | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0045 | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0060 | transmed:TMO_0046 | An arm of clinical study is a population that participates in a clinical trial and is subject to some intervention. | IAO:0000120\ | linkedct:trial_arm_group | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0124 | arm of clinical study | |||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0010 | biomedical measure | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0093 | transmed:TMO_0010 | A biomedical measure is an information content entity that describes or is a measure of biomedically relevant entities. | biomedical measure | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0023 | symptom | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0019 | transmed:TMO_0023 | Richard Scheuermann, Werner Ceusters, Barry Smith in "Toward an Ontological Treatment of Disease and Diagnosis""" | A quality of a patient that is observed by the patient or a processual entity experienced by the patient, either of which is hypothesized by the patient to be a realization of a disease. | UMLS:C1457887\ | CPR:symptom\ | ACGT:Symptom\ | NCIt:Symptom | symptom | ||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0064 | active ingredient role | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0062 | transmed:TMO_0064 | An active ingredient role is a role played by a chemical substance which has the disposition to treat a certain disease and is part of a pharmaceutical formulation. | active ingredient role | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0077 | clinical trial criterion | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0151 | transmed:TMO_0077 | A clinical trial criterion is a directive information entity which, if satisfied, contributes to the inclusion or exclusion of candidate patients. | clinical trial criterion | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0147 | temporal quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0146 | transmed:TMO_0147 | temporal quantity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0082 | gene variant | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0082 | A gene variant is a variant of another gene based on some difference in sequence (composition and connectivity) | gene variant | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0117 | magnitude of a genetic marker | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0102 | transmed:TMO_0117 | A magnitude of a genetic marker refers to the the significance of some genetic marker | magnitude of a genetic marker | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0095 | toxic | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0056 | transmed:TMO_0095 | toxic | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0165 | gene symbol | false | http://purl.obolibrary.org/obo/IAO_0000028 | transmed:TMO_0165 | gene symbol | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0218 | companion diagnostic role | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0221 | transmed:TMO_0218 | companion diagnostic role | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0183 | kilogram | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0104 | transmed:TMO_0183 | kilogram | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0135 | medical description | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | transmed:TMO_0135 | medical description | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0170 | publication date | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0169 | transmed:TMO_0170 | publication date | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0016 | clinical protocol | false | http://purl.obolibrary.org/obo/IAO_0000033 | transmed:TMO_0016 | A clinical protocol is a directive information entity about the objective(s), design, methodology, statistical considerations, and organization of a clinical procedure. | IAO:0000124 | clinical protocol | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0088 | female | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0086 | transmed:TMO_0088 | Female is a sex quality for which sex organs contain only female gametes | female | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0158 | item in collection identifier | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0137 | transmed:TMO_0158 | An item in a collection identifier is an identifier for an entity that is a member of a collection. | item in collection identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | molecular entity | false | http://www.ifomis.org/bfo/1.1/snap#MaterialEntity | transmed:TMO_0034 | Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity. | GRO:MolecularEntity\ | CHEBI:23367 | molecular entity | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0104 | unit of measurement | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0099 | transmed:TMO_0104 | unit of measurement | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0189 | milligram per week | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0188 | transmed:TMO_0189 | milligram per week | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0122 | chromosomal sequence position | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0126 | transmed:TMO_0122 | A chromosomal nucleotide sequence position is an ordinal number which reflects the position of a nucleotide in relation to the first nucleotide of the same chromosome. | chromosomal sequence position | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0176 | pharmgkb sample identifier | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0158 | transmed:TMO_0176 | pharmgkb sample identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0140 | regionally-defined human population | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0139 | transmed:TMO_0140 | A collection of humans from a particular region. | regionally-defined human population | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0181 | height in centimeters | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0150 | transmed:TMO_0181 | height in centimeters | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000033 | IAO_0000033 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | obo2:IAO_0000033 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0229 | genotype with allele | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0080 | transmed:TMO_0229 | A genotype containing one matching allele on each chromosome (e.g., CYP2C9*1/*3) | genotype with allele | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0194 | medical descriptor | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0135 | transmed:TMO_0194 | medical descriptor | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000310 | IAO_0000310 | false | obo2:IAO_0000310 | drugbank:references | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0180 | weight in kilograms | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0149 | transmed:TMO_0180 | weight in kilograms | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0021 | clinical trial protocol | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0016 | transmed:TMO_0021 | A clinical trial protocol is a clinical protocol about the objective(s), design, methodology, statistical considerations, and organization of a clinical trial. | clinical trial protocol | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0075 | planned process | false | http://www.ifomis.org/bfo/1.1/span#ProcessualEntity | transmed:TMO_0075 | A planned process is a process in which specific objectives are realized in a plan designed by some agent. | OBI:0000011\ | BIRNLex:11021 | planned process | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.ifomis.org/bfo/1.1/snap#Role | Role | false | http://www.w3.org/2002/07/owl#Thing | snap:Role | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0115 | pharmacodynamic measure | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100 | transmed:TMO_0115 | pharmacodynamic measure | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0080 | genotype | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0228 | transmed:TMO_0080 | In this context, a genotype is a material entity made up of two DNA regions on two homologous chromosomes in a diploid cell. One chromosome is derived from the father and one is derived from the mother. The two DNA regions are located at the same genetic locus on each of the two chromosomes. | genotype | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0093 | measure | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0093 | A measure is an information content entity that describes or quantifies some thing. | measure | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0128 | sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | transmed:TMO_0128 | A sequence is an ordered list of objects of a specified type. | sequence | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0169 | date | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0147 | transmed:TMO_0169 | date | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0146 | physical quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0099 | transmed:TMO_0146 | physical quantity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0120 | numerical quantity selected from a continuous variable | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0099 | transmed:TMO_0120 | numerical quantity selected from a continuous variable | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0133 | single letter amino acid sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0129 | transmed:TMO_0133 | single letter amino acid sequence | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0151 | criterion | false | http://purl.obolibrary.org/obo/IAO_0000033 | transmed:TMO_0151 | criterion | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0221 | diagnostic role | false | http://www.ifomis.org/bfo/1.1/snap#Role | transmed:TMO_0221 | diagnostic role | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0045 | population | false | http://www.ifomis.org/bfo/1.1/snap#MaterialEntity | transmed:TMO_0045 | A population is a collection of organisms. | dcterms:AgentClass\ | IAO:0000120\ | OCRe_research:Population | population | ||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0086 | sex | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | transmed:TMO_0086 | Sex is an quality that inheres in an organism for which sexual differentiation is required for sexual reproduction. | sex | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0099 | numerical quantity | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0094 | transmed:TMO_0099 | numerical quantity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000028 | IAO_0000028 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0137 | obo2:IAO_0000028 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0032 | clinical trial | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0029 | transmed:TMO_0032 | A clinical trial is a study to assess the efficacy of a substance for the treatment of a condition. | HL7V3.0:CLNTRL\ | linkedct:trials\ | SNOMEDCT:110465008\ | IAO:0000121\ | NCIt:Clinical_Trial\ | MSH:D016430 | clinical trial | |||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0050 | drug efficacy | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100 | transmed:TMO_0050 | Drug efficacy is a measure of the capabilty of a drug to produce an intended effect as a function of its concentration. | IAO:0000124 | drug efficacy | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0091 | temporal quality | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0109 | transmed:TMO_0091 | temporal quality | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0139 | human population | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0045 | transmed:TMO_0139 | A collection of humans | human population | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0144 | organism | false | http://www.ifomis.org/bfo/1.1/snap#MaterialEntity | transmed:TMO_0144 | organism | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0157 | chromosome number | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0158 | transmed:TMO_0157 | A chromosome number is an identifier for a chromosome that identifies it from a collection of chromosomes for a given organism. | chromosome number | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0192 | ratio | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0100 | transmed:TMO_0192 | ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0227 | genotype with multiple nucleotide polymorphism | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0080 | transmed:TMO_0227 | A genotype with a multiple-nucleotide polymorphism (MNP). An MNP is a variation of several adjacent nucleotides in the genomes of members of a species. For a variation to be considered an MNP, it must occur in at least 1% of the population. | genotype with multiple nucleotide polymorphism | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0057 | dosage | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0113 | transmed:TMO_0057 | Dosage is the amount of a chemical administered to, or taken by, an organism and expressed as some function of the organism and of time (mg/kg body weight/day). | EFO:0000428\ | UMLS:C0178602\ | SNOMEDCT:260911001\ | LNC:LP6801-7\ | NCIt:Dose | dosage | ||||||||||||||||||||||||||||||||||||||||||||||
| http://purl.obolibrary.org/obo/IAO_0000300 | IAO_0000300 | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0089 | obo2:IAO_0000300 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0003 | inactive ingredient | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0071 | transmed:TMO_0003 | An inactive ingredient is a pharmaceutical ingredient that is part of a pharmaceutical formulation but does not have the disposition to treat a certain disease. | HL7V3.0:IACT | inactive ingredient | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0162 | ncbi reference snp identifier | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0161 | transmed:TMO_0162 | ncbi reference snp identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0043 | adverse drug event | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0061 | transmed:TMO_0043 | CDISC glossary | An adverse drug event is a any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. | SNOMEDCT:406644009\ | MSH:D004362\ | sider:side_effects | adverse drug event | |||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0056 | toxicity | false | http://www.ifomis.org/bfo/1.1/snap#Quality | transmed:TMO_0056 | Toxicity is a quality of a chemical substance which indicates the capacity to cause injury to an organism in a dose dependent manner. | ACGT:Toxicity\ | NCIt:Toxicity\ | MSH:Q000633\ | UMLS:C0600688 | toxicity | |||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0126 | deoxyribonucleotide sequence position | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0125 | transmed:TMO_0126 | A dexoyribonucleotide sequence position is an ordinal number which reflects the position of a deoxyribonucleotide in relation to the first deoxyribonucleotide of the same deoxyribonucleic acid (DNA). | deoxyribonucleotide sequence position | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0131 | DNA sequence | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0130 | transmed:TMO_0131 | a DNA sequence is a sequence of characters that represents the composition and connectivity of a a DNA molecule. | DNA sequence | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0198 | race | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0084 | transmed:TMO_0198 | race | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0061 | side effect | false | http://www.ifomis.org/bfo/1.1/span#ProcessualEntity | transmed:TMO_0061 | A side effect is an effect of an intervention, whether therapeutic or adverse, that is secondary to the intended effect of the intervention. | NCIt:Side_Effect | side effect | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0168 | molecular complex | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0034 | transmed:TMO_0168 | molecular complex | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0009 | medical expert role | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0074 | transmed:TMO_0009 | An medical expert role is a role played by a human in a clinical context who is involved in the assessment or administration of treatment or its results. | OCRe_clinical:Clinician | medical expert role | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0225 | genotype with indel variation | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0080 | transmed:TMO_0225 | A genotype of which variants exist that differ though an insertion, deletion or a combination thereof. | genotype with indel variation | |||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0014 | inclusion criterion for clinical trial | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0077 | transmed:TMO_0014 | A inclusion criterion for clinical trial is a clinical trial criterion which, if satisfied, supports the inclusion of candidate patients. | IAO:0000124 | inclusion criterion for clinical trial | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0027 | institutional payer | This is, at the moment, a kind of institution because the payers are typically insurance companies or government bodies. But it is possible in some jurisdictions to pay for treatment oneself. Treat by renaming to "institutional payer"". --CRB" | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0025 | transmed:TMO_0027 | UMLS:C2348942\ | NCIt:Healthcare_Payer | institutional payer | |||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0068 | diagnostic criterion | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0151 | transmed:TMO_0068 | A diagnostic criterion is a directive information entity for consideration during a diagnosis which, if satisfied, contributes to a diagnostic result | IAO:0000124 | diagnostic criterion | ||||||||||||||||||||||||||||||||||||||||||||||||||
| http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0000 | active ingredient | false | http://www.w3.org/2001/sw/hcls/ns/transmed/TMO_0071 | transmed:TMO_0000 | An active ingredient is a pharmaceutical ingredient that has the disposition to treat a certain disease. | HL7V3.0:ACTI | active ingredient |
(Aquí van las primeras 200 filas de 225; sigue en la caja.)